Isodiol International (ISOLF) Stock Price, News & Analysis

Company Overview

Isodiol International Inc. (OTCMKTS:ISOLF) is a Canadian biotechnology and nutraceutical company focused on the development, manufacturing and marketing of phytocannabinoid-based products. Headquartered in Kelowna, British Columbia, with additional facilities in the United States, the company specializes in the extraction and formulation of high-purity cannabidiol (CBD) ingredients catering to health and wellness, pharmaceutical, beauty and skincare markets. Isodiol’s business model spans the full value chain, from seed to finished goods, supported by in-house extraction capabilities and standard-compliant manufacturing processes.

The company’s portfolio encompasses a wide range of CBD-infused offerings, including oils, tinctures, capsules, topical creams, cosmetics and pet care products. Under brands such as NutraCea and LivRelief, Isodiol markets finished formulations direct to consumers through e-commerce channels as well as to business-to-business customers across North America and select international markets. In addition, its Meristem Crop Performance division provides plant health and biocontrol solutions designed to enhance cannabinoid crop yields and quality for cultivators, reflecting the company’s commitment to integrated agronomic and product development expertise.

Since its entrance into the U.S. market following the passage of the 2018 U.S. Farm Bill, Isodiol has pursued strategic acquisitions and partnerships to broaden its geographic footprint and diversify its supply chain. The company is led by Bill Milne, Chief Executive Officer, who brings extensive experience in international sales and business development within the nutraceutical and wellness industries. Isodiol continues to invest in research and development to expand its product offerings and support regulatory compliance across its operational jurisdictions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 167 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ISOLF
• CIK: N/A
• Web: isodiol.com
• Phone: (855) 707-6100
• Fax: N/A
• Employees: 57
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A